Biography
Dr Adam Byrne is committed to providing exceptional patient care through a personalised and forward-thinking approach. He combines clear communication with evidence-based practice, working closely with patients and their loved ones to support the best possible outcomes.
Dr Adam Byrne is a radiation oncologist at Icon Cancer Centre Winsor Gardens. In 2016, he completed a Bachelor of Medicine, Bachelor of Surgery, and Bachelor of Obstetrics (MB BCh BAO) at the National University of Ireland, Galway before undertaking specialist training across the South Australia and Northern Territory training network. In 2024, he was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (RANZCR).
Dr Byrne has published research in peer-reviewed journals and is actively involved in clinical education, mentorship and quality improvement initiatives. He previously served as Consultant Radiation Oncologist and Director of Training in Radiation Oncology at the Royal Hobart Hospital, while also practising privately at Icon Cancer Centre Hobart. He is currently Consultant Radiation Oncologist and Medical Lead, Radiation Oncology Quality & Safety, at the Royal Adelaide Hospital. In 2025, he contributed to the development of national skin cancer guidelines through his role on the eviQ Reference Committee for Skin Cancer Radiation Therapy.
He has extensive experience across a broad range of cancer types, with a special clinical interest in central nervous system (CNS) tumours, head and neck cancer, lung cancer, and skin cancer. Dr Byrne specialises in advanced radiotherapy therapy techniques, including stereotactic ablative body radiotherapy, stereotactic radiosurgery, and palliative radiotherapy.
Publications
Byrne A, De Abreu Lourenco R, Govindaraj R, Ball D, Le H. A cost-effectiveness analysis of stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the management of stage 1 non-small-cell lung cancer: Results from the TROG 09.02 CHISEL study. J Med Imaging Radiat Oncol. 2024 Oct 09.
Alnsour A, Le H, Byrne A, Rodgers N, Roos D. Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report. J Med Case Rep. 2023 Jun 14;17(1):273.
Ong WL, Byrne A, Chelvarajah R, Chong C, Gallo J, Kain M, Khong J, O’Reilly E, Udovicich C, Weeransinghe C, Zhong Hu TC, Bece A. Survey of brachytherapy training experience among radiation oncology trainees and fellows in the Royal Australian and New Zealand College of Radiologists (RANZCR). J Med Imaging Radiat Oncol. 2022 Oct;66(7):980-992.
Govindaraj R, Khong J, Byrne A, Zacest A, Roos D. The Effect of Cochlear Dose on Hearing Preservation After Low-Dose Stereotactic Radiosurgery for Vestibular Schwannomas: A Systematic Review. Adv Radiat Oncol. 2022 Aug 28;7(6):101059.